Answers are grounded in this paper and cite their sources.
Background: Plasma medicine has emerged as a promising approach for cancer treatment, with reactive oxygen and nitrogen species generated by plasma contributing to cellular stress and tumor cell death. However, the effects of plasma treatment on membrane transporter regulation remain poorly understood. Methods: This study investigated whether plasma exposure alters the gene expression of pharmacologically and biologically relevant transporters across diverse cancer cell lines, and whether these responses are conserved in an in ovo tumor model. Twelve cancer cell lines representing squamous cell carcinoma, melanoma, and adenocarcinoma were treated with plasma at cell line-specific IC25 conditions. The expression of ten transporter genes was assessed by targeted quantitative PCR. Results: Plasma treatment induced heterogeneous changes in transporter gene expression, with both up- and downregulation observed across cell lines and transporters. SLC2A2, ABCC2, SLCO3A1, and SLC28A3 displayed particularly pronounced and distinct response patterns. Correlation analysis further identified coordinated changes among several transporter genes, suggesting shared response patterns to plasma-induced stress. Selected transporter responses were subsequently assessed in an in ovo tumor model, revealing partial conservation of plasma-induced transcriptional regulation alongside substantial context-dependent differences in response magnitude and direction. Conclusions: These findings demonstrate that plasma treatment can modulate transporter gene expression in a heterogeneous and cell line-dependent manner. The observed regulation may reflect broader cellular adaptations to plasma-induced stress and could have implications for cellular drug handling and pharmacological response.
No takes yet. Share an insight, caveat, or question.
Singer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: